IP Library Granted Patent US 9,101,580
Granted Patent B2
US 9,101,580 · App. 13/718,065 · Granted Aug 11, 2015

Compositions and methods for treating traumatic brain injury

Inventors: Matthew Bennett (Toronto, CA); Gus Peller (Toronto, CA)
Assignees: Matthew Bennett; Gus Peller
A61K36/16A61K31/12A61K31/122A61K31/185A61K31/197A61K31/198A61K31/202A61K31/205A61K31/352A61K31/353A61K31/385A61K31/4045A61K31/685A61K31/7004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,101,580
App. No.
13/718,065
Granted
Aug 11, 2015
Kind
B2
Abstract

The disclosure provides compositions treating traumatic brain injuries such as concussions. In one embodiment, the composition comprises phosphatidylserine, phosphatidylcholine, quercetin, astaxanthin, R-alpha lipoic acid, N-acetyl cysteine, taurine, L-glutamine, carnitine, D-ribose, creatine, epigallocatechin gallate, melatonin, ginkgo leaf extract, curcumin and L-glycine. The disclosure also provides methods for treating traumatic brain injuries such as concussions by administering an effective amount of the compositions described within.

Claims (9)

1. A method of treating a traumatic brain injury in a subject, comprising administering an effective amount of a composition comprising at least 8 components selected from the group consisting of: phosphatidylserine, phosphatidylcholine, quercetin, astaxanthin, R-alpha lipoic acid, N-acetyl cysteine, taurine, L-glutamine, carnitine, D-ribose, creatine, epigallocatechin gallate, melatonin, ginkgo leaf extract, curcumin, and L-glycine to the subject.

2. The method of claim 1 , wherein 50-4500 mg phosphatidylserine, 100-4500 mg phosphatidylcholine, 100-2000 mg quercetin, 0.5-12 mg astaxanthin, 100-4000 mg R-alpha lipoic acid, 100-5000 mg N-acetyl cysteine, 500-8000 mg taurine, 500-50000 mg L-glutamine, 500-30000 mg carnitine, 500-30000 mg D-ribose, 500-30000 mg creatine, 50-5000 mg epigallocatechin gallate, 0.1-15 mg melatonin, 50-1000 mg ginkgo leaf extract, 100-3000 mg curcumin, and/or 500-6000 mg L-glycine is administered to the subject.

3. The method of claim 1 , wherein phosphatidylserine, phosphatidylcholine, quercetin, R-alpha lipoic acid, L-glutamine, taurine, carnitine and D-ribose are administered to the subject.

4. The method of claim 1 , wherein astaxanthin, N-acetyl cysteine, creatine, epigallocatechin gallate, melatonin, ginkgo leaf extract, curcumin and L-glycine are administered to the subject.

5. The method of claim 1 , wherein phosphatidylserine, phosphatidylcholine, quercetin, astaxanthin, R-alpha lipoic acid, N-acetyl cysteine, taurine, L-glutamine, carnitine, D-ribose, creatine, epigallocatechin gallate, melatonin, ginkgo leaf extract, curcumin and L-glycine are administered to the subject.

6. The method of claim 1 , wherein the traumatic brain injury is a concussion.

7. The method of claim 1 , wherein the composition is administered one to three times a day to the subject.

8. The method of claim 1 , wherein the composition is administered one to three times a day for at least one, two, six, twelve or twenty-four months.

9. The method of claim 1 , wherein the composition is administered orally to the subject.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2021
From: BENNETT, MATTHEW; PELLER, GUS
To: 9269932 CANADA INC., DBA BENNETT'S CHOICE
Reel/Frame 059526/0242 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2021
From: 9269932 CANADA INC.
To: HAVN LIFE SCIENCES INC.
Reel/Frame 058149/0173 →
Continuity (1)
Related Publication 20140170211A1 · Jun 19, 2014